The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial

Gillian M Duchesne; Henry H Woo

Journal article

The 'Timing of Androgen-Deprivation therapy in incurable prostate cancer' protocol (TOAD) where are we now? Synopsis of the Victorian Cooperative Oncology Group PR 01-03 and Trans-Tasman Radiation Oncology Group 03.06 clinical trial

Gillian M Duchesne, Henry H Woo

BJU International | WILEY | Published : 2014

DOI: 10.1111/bju.12864

University of Melbourne Researchers

Gill Duchesne Author The Sir Peter MacCallum Department of Oncology

Related Projects (1)

A clinical trial to determine the optimal timing of androgen deprivation in relapsed or non-curable prostate cancer

The aim of the study is to clarify when is the optimal time to start hormone treatment for men with certain stages of prostate cancer. It ha..

Grants

Funding Acknowledgements

This work was funded by the National Health and Medical Research Council (NHMRC), a multistate Cancer Council grant, the Royal Australian and New Zealand College of Radiologists (RANZCR) and an educational grant for data management from Mayne Pharma.